DPAC

What DPAC does

The Diabetes Patient Advocacy Coalition (DPAC) is a 501(c)(4) nonprofit patient advocacy organization founded in 2015 and headquartered in St. Petersburg, Florida. It operates a grassroots coalition of people with diabetes, caregivers, patient advocates, health professionals, and partner organizations working to influence diabetes-related policy at state and federal levels. DPAC's stated mission is to ensure quality of and access to care, medications, and devices for people living with diabetes, and to educate, inspire, and empower patient advocates as well as lawmakers toward meaningful action on diabetes. The organization's priority policy areas include insulin price caps, pharmacy benefit manager (PBM) rebate reform, copay accumulator reform, Medicaid protection, GLP-1 coverage under Medicare and Medicaid, and access to diabetes technology such as CGMs and insulin pumps.

DPAC delivers its work through several programs rather than a technology platform: the Champions Program, which trains and mobilizes volunteer advocates across all 50 states; DPAC Dialogues, a series of educational webinars including 'Brown Bag' lunch-and-learn sessions; the Act Now platform for constituent engagement with legislators; and the annual State Legislative Diabetes and Obesity Handbook (2025 Edition). In October 2023, DPAC and the Diabetes Leadership Council (DLC) secured a federal court ruling from Judge John D. Bates of the U.S. District Court for the District of Columbia striking down an HHS rule that permitted health insurers to exclude manufacturer copay assistance from patients' out-of-pocket cost calculations. In March 2022, DPAC co-founded the Patient Pocket Protector Coalition, a 20+ member organization coalition focused on PBM rebate reform.

DPAC is led by CEO George Huntley, who also serves as CEO of DLC, with L. Hunter Limbaugh as Board Chair and Erin M. Callahan as Chief Operating Officer. The organization has a small staff of 1–10 employees. As a 501(c)(4), DPAC is funded through membership support, donations, and corporate sponsorships rather than commercial product sales, and it does not develop proprietary technology products. DPAC does not publicly disclose revenue or financial statements, and its addressable population is estimated at 38.4 million Americans with diabetes, 88 million adults with prediabetes, and 122 million total with or at risk.

Name

DPAC

Legal name

Diabetes Patient Advocacy Coalition

Website

https://diabetespac.org

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

DPAC is a 501(c)(4) nonprofit patient advocacy coalition that trains volunteer Champions across all 50 states to influence state and federal diabetes policy, focusing on insulin affordability, PBM reform, and access to diabetes medications and technology.

Ownership category

akta.pro rank

Product category

Patient Advocacy Services

NAICS

Social Advocacy Organizations (8133), Political Organizations (813940)

SIC

Services-Social Services (8300)

akta.pro primary industry

Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL)

Keywords

• Patient advocacy
• Diabetes policy
• Healthcare advocacy
• Grassroots coalition
• Legislative advocacy

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Nonprofit Advocacy Organization: DPAC is a 501(c)(4) tax-exempt nonprofit organization that relies on membership support, donations, and potentially corporate sponsorships from diabetes-related companies to fund advocacy activities. The organization does not generate commercial revenue from products or services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

DPAC is a 501(c)(4) nonprofit grassroots coalition that trains and mobilizes volunteer patient advocates (Champions) to influence state and federal policy on diabetes care, insulin affordability, PBM reform, Medicaid protection, and access to diabetes technology and medications. It provides advocacy resources, educational webinars, policy handbooks, and direct constituent-to-legislator engagement tools at no cost to participants.

Product overview

DPAC is a 501(c)(4) patient advocacy coalition that provides advocacy programs and resources rather than a traditional product platform. Its offerings include the DPAC Champions Program for volunteer advocates, the State Legislative Diabetes and Obesity Handbook for policy reference, DPAC Dialogues webinars for education, and an Act Now platform for constituent engagement with policymakers. The organization also provides tools like the Insurance Cost Worksheet to help patients navigate coverage decisions.

Differentiator

Problem solved

Functional benefit

Products and services

• DPAC Champions Program A volunteer advocate program connecting people with diabetes to state and federal advocacy opportunities, providing monthly legislative updates and event invitations including Brown Bag lunch-and-learn webinars.
• State Legislative Diabetes and Obesity Handbook An annual state-by-state legislative reference handbook on diabetes and obesity policies, updated annually with the 2025 Edition available.
• DPAC Dialogues Educational webinars including Brown Bag lunch-and-learn sessions on relevant topics in diabetes policy and care.
• Act Now Campaign A platform enabling constituents to contact policymakers on diabetes-related legislation and policy issues.
• Insurance Cost Worksheet A downloadable spreadsheet tool to help individuals compare insurance plans and costs for diabetes care.

Quantifiable outcome

• Successful court victory striking down HHS rule on copay accumulator adjustment programs (October 2023)
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

13 partnerships are on record, tiered core and supporting.

• Diabetes Leadership Council (DLC)coreStrategic or Co-development PartnerDLC is a 501(c)(3) patient advocacy organization that unites former leaders of national diabetes organizations. DPAC and DLC frequently issue joint statements on policy issues and collaborate on advocacy campaigns including PBM reform, copay accumulator lawsuits, and GLP-1 coverage advocacy.
• Patient Pocket Protector Coalition (PPPC)coreStrategic or Co-development PartnerCoalition founded by DPAC in March 2022 to address PBM rebate reform and protect patients from high drug costs. Includes 20+ member organizations including Alliance for Transparent & Affordable Prescriptions, Autoimmune Association, Children with Diabetes, Community Oncology Alliance, National Community Pharmacists Association, and others.
• The Diabetes LinksupportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• T1D ExchangesupportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• Breakthrough T1D (formerly JDRF)supportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• Endocrine SocietysupportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• diaTribe FoundationsupportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• Diabetes SisterssupportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• Children With DiabetessupportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• Beyond Type 1supportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• American Diabetes AssociationsupportingOthersListed as a DPAC partner organization supporting diabetes advocacy efforts
• HIV+Hepatitis Policy InstitutecoreStrategic or Co-development PartnerPartnered with DPAC and DLC to file lawsuit challenging HHS rule on copay accumulator adjustment programs (2022) and filed amicus brief supporting the lawsuit. 29 patient and consumer organizations joined the amicus brief.
• McDermott Will & Emery LLPsupportingOthersLaw firm representing DPAC and DLC in the copay accumulator lawsuit against HHS

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Diabetes Leadership Council (DLC): Sister 501(c)(3) organization sharing the same CEO (George Huntley) and leadership; co-files litigation and joint statements with DPAC on diabetes policy. Directly comparable in mission, governance, and operating model.
• National Patient Advocate Foundation: National nonprofit dedicated to patient-centered policy advocacy on access, affordability, and health equity. Closely aligned with DPAC's mission of elevating the patient voice in federal and state health policy.
• HIV+Hepatitis Policy Institute: DC-based patient advocacy organization that partnered with DPAC and DLC to file the copay accumulator lawsuit against HHS. Comparable as a small-staff, litigation-active policy advocacy nonprofit.
• The Diabetes Link: Diabetes patient advocacy nonprofit focused on young adults and emerging adults living with diabetes. Listed DPAC partner; comparable size and mission in grassroots patient policy advocacy.

Broad incumbents

• American Diabetes Association (ADA): Established national diabetes nonprofit with research, education, and advocacy arms. Listed as a DPAC coalition partner; far larger and broader in scope but overlapping on diabetes policy advocacy.
• Breakthrough T1D (formerly JDRF): Major T1D-focused nonprofit operating advocacy, research funding, and community programs. Listed DPAC partner; substantially larger and more research-centric, but overlaps on diabetes access policy.
• diaTribe Foundation: Diabetes-focused nonprofit focused on patient education, advocacy, and policy. Listed DPAC partner; broader scope spanning content, advocacy, and patient engagement on diabetes access.

Emerging players

• Beyond Type 1: Nonprofit focused on the Type 1 diabetes community with advocacy and education programs. Listed DPAC partner; smaller scale but overlapping patient advocacy work for T1D access issues.
• T1D Exchange: Research and patient-outcomes nonprofit for Type 1 diabetes. Listed DPAC partner; differs by leaning clinical/data but overlaps on community advocacy and policy engagement.
• Children with Diabetes: Nonprofit focused on children and families affected by diabetes, providing education, conferences, and advocacy support. Coalition partner of DPAC with comparable niche diabetes patient advocacy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/diabetespac
• YouTubeyoutube.com/channel/UCqSIkH06DsRveTwEbDCrMXg
• Facebookfacebook.com/DiabetesPAC
• LinkedInlinkedin.com/company/diabetes-patient-advocacy-coalition
• Instagraminstagram.com/diabetespac

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DPAC